Our study showed that the expression levels of MFN1, MFN2, and OPA1 protein were downregulated after cerebral ischemia–reperfusion, and 14, 15‐EET treatment inhibited the downregulation of these proteins and promoted mitochondrial fusion. The gene discussed is MFN2; the disease is Cerebral ischemia.